Aim: To assess outcome of chemoradiotherapy for organ preservation in muscle invasive bladder cancer.
Material And Methods: 41 patients treated between January 2010 to January 2015 were evaluated in the present study. All patients T staged ranging from cT2-T4a and had undergone maximal transurethral resection of bladder tumour (TURBT).